The San Diego Conference is now in its third decade of highlighting cutting-edge technologies that help you understand the molecular basis of human disease. This year, the AACC conference will examine how molecular and genetic tools can be the catalyst of synergy in the combined field of diagnostics and therapeutics/drug discovery.
As in previous years, the program is comprised of five sessions: Sequencing & Haplotyping; Epigenetics & Cancer; Applications; Multivariate Analysis and Genetic Testing; and Infectious Disease Testing. Each session features presentations covering a number of emerging technologies and diagnostic tools, offered by recognized experts in the field.
For more information or to register, www.aacc.org/AACC/events/meetings/meetingdetail.htm?ID=4688&PH=Conference
|
